Osr Holdings, Inc. (OSRHW) — 10-Q Filings

10-Q Filings (6)

• OSR Holdings' Net Loss Widens to $19.8M Amidst Acquisition Costs — Nov 12, 2025 Risk: high
  OSR Holdings, Inc. reported a net loss of $3.19 million for the three months ended September 30, 2025, a slight improvement from the $3.36 million net loss in t
• OSR Holdings' Net Loss Widens Amidst Soaring Costs Post-Merger — Aug 14, 2025 Risk: high
  OSR Holdings, Inc. reported a significant net loss of $5,225,198 for the three months ended June 30, 2025, a substantial increase from the $2,277,488 net loss i
• OSR Holdings, Inc. Files Q1 2025 10-Q Report — May 20, 2025 Risk: low
  OSR Holdings, Inc. filed its 10-Q for the quarterly period ended March 31, 2025. The company, formerly known as Bellevue Life Sciences Acquisition Corp., is inc
• Bellevue Life Sciences Acquisition Corp. Files 10-Q — Nov 14, 2024 Risk: low
  Bellevue Life Sciences Acquisition Corp. filed its 10-Q for the period ending September 30, 2024. The company, incorporated in Delaware, operates in the Surgica
• Bellevue Life Sciences Acquisition Corp. Files Q2 2024 10-Q — Aug 19, 2024 Risk: low
  Bellevue Life Sciences Acquisition Corp. filed its 10-Q for the period ending June 30, 2024. The company, incorporated in Delaware, operates in the Surgical & M
• Bellevue Life Sciences Acquisition Corp. Files 10-Q for Period Ending March 31, 2024 — May 15, 2024 Risk: medium
  Bellevue Life Sciences Acquisition Corp. (OSRHW) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. Bellevue Life Sciences Acquisition Corp. filed a

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX